Guess how many of those alternative funds still exist? 341. The other 1,000 or so have been liquidated or merged away, a 75% ...

This year Trump put new tariffs of 30% on Chinese goods, although there are some exemptions, such as smartphones and laptops. That's down from 145%, as the two sides gave each other time to work out a ...

Purchasers of long-term-care insurance have gotten slammed with premium increases. What to know if you’re considering it.

The chief executive officer of GitHub, Microsoft's coding unit, plans to leave the company after about four years in the role. Thomas Dohmke said Monday he plans to stay on through the end of 2025 ...

Dow Jones Top Markets Headlines at 1 PM ET: U.S. Stocks Mixed; China Trade Talks to Dominate Week | Trump ... U.S. stocks were mixed as much chatter centered on Nvidia and AMD's unusual deal to pay ...

Dow Jones Top Company Headlines at 1 PM ET: Multiple People Injured After Explosion at U.S. Steel Plant in Pennsylvania | Ford's ... Multiple People Injured After Explosion at U.S. Steel Plant in ...

For instance, if you convert $10,000 from an IRA to a Roth IRA, and that $10,000 is subject to a 12% rate, the federal tax bill is $1,200. If in the future you were expecting a 22% rate on a $10,000 ...

The souring mood that results when we realize that summer is almost over is a type of seasonal affective disorder (SAD), and several studies have found that SAD leads to poor stock-market returns.

Intuit Down Nearly 5%, on Pace for Largest Percent Decrease Since April — Data Talk Intuit Inc. (INTU) is currently at $711.74, down $37.26 or 4.97% --Would be lowest close since May 22, 2025, when it ...

The STOXX Europe 600 Index is down 0.32 point or 0.06% today to 546.76 --Off 2.91% from its record close of 563.13 hit Monday, March 3, 2025 ...

The Montana Facility Finance Authority will sell $113.4 million of revenue bonds to be loaned to Benefis Health System to finance the costs of certain hospital campus projects.

Shares of Tiziana Life Sciences gained after the biotechnology company said the Food & Drug Administration approved the investigational new drug application for a trial of its treatment for multiple ...